HealthInsightUK has a number of contributors who are experts in statins. Here three of them – Dr John Briffa, Zoë Harcombe and Aidan Goggins respond to the CTT investigation. They explain why side-effect data is unreliable and disagree about whether it is in the drug companies interest that the risk of side-effects is downplayed or is that part of cunning plan? (Read more…)
Current Posts – 13 Apr 2014
Alzheimer’s is one of the most feared disorders, caring for sufferers threatens to bankrupt the NHS and there is growing evidence that your risk is related to known life-style factors. So how many hundreds of millions are being spent to identify those at risk – there are tests already available – and putting them on programs to reduce it? None. In fact less than 2% of Alzheimer’s research goes on ways to improve prevention. Patrick Holford explains how to help yourself.